| Literature DB >> 35052006 |
Barbara Zieger1, Doris Boeckelmann1, Waseem Anani2, Hervé Falet2,3, Jieqing Zhu2,4, Hannah Glonnegger1, Hermann Full5, Felicia Andresen1, Miriam Erlacher1, Ekkehart Lausch6, Salome Fels1, Brigitte Strahm1, Peter Lang7, Karin M Hoffmeister2,8.
Abstract
The GNE gene encodes an enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid, a precursor of sialic acids. GNE mutations are classically associated with Nonaka myopathy and sialuria, following an autosomal recessive and autosomal dominant inheritance pattern. Reports show that single GNE variants cause severe thrombocytopenia without muscle weakness. Using panel sequencing, we identified two novel compound heterozygous variants in GNE in a young girl with life-threatening bleedings, severe congenital thrombocytopenia, and a platelet secretion defect. Both variants are located in the nucleotide-binding site of the N-acetylmannosamin kinase domain of GNE. Lectin array showed decreased α-2,3-sialylation on platelets, consistent with loss of sialic acid synthesis and indicative of rapid platelet clearance. Hematopoietic stem cell transplantation (HSCT) normalized platelet counts. This is the first report of an HSCT in a patient with an inherited GNE defect leading to normal platelet counts. Thieme. All rights reserved.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35052006 DOI: 10.1055/s-0041-1742207
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 6.681